Announcements 08.21.2025
Forty-Two Choate Attorneys Recognized in Best Lawyers in America® 2026
The Best Lawyers in America® has recognized 42 Choate attorneys in its 2026 edition. Recognition in Best Lawyers® is based entirely on peer review and is widely regarded by both clients and legal professionals as a significant honor.
Events 05.22.2025
Margo Monroe Speaking at Boston University Biomedical Engineering Career Panel
Margo Monroe will speak on the “Biomedical Engineering Career Panel & Networking Event” at Boston University on Friday, May 30th from 4:00 to 6:00 p.m., presented by the BME Graduate Student Council.
Announcements 05.01.2025
Choate Elevates Six to Principal in 2025
Six Choate attorneys – Melissa Adams, Leila Cetrone, Jill Gately, Emily Miller, Margo Monroe, and Matt Mortensen – have been elected as principals, effective May 1, 2025.
Events 08.21.2024
Margo Monroe Speaking on Tech Transfer and Commercialization at IPWatchdog Women's IP Forum
Dr. Margo Monroe will join the panel "Tech Transfer and the Commercialization Process," at the IPWatchdog Women's IP Forum on Tuesday, August 27, 2024 at 9:00 a.m. EST.
Announcements 08.20.2024
Universal DX (UDX) Closes Series B Funding for Clinical Trials on Colorectal Cancer Screening Blood Test, Signal-C®
Choate represented Universal DX (UDX) in IP diligence for its Series B funding round, which will advance the clinical trial of Signal-C, UDX’s colorectal cancer screening blood test, which is on track to enroll 15,000 patients across 100 sites.
Events 03.28.2024
Margo Monroe to Present Intellectual Property 101 at Boston University
Margo Monroe will present "Intellectual Property 101" at Boston University on Friday, April 5, 2024, discussing the basics of IP protection and competitive positioning strategies for building a life sciences or technology company.
Publications 11.14.2023
IPWatchdog Life Sciences Masters 2023 Takeaways
Key takeaways compiled by Choate attorneys who recently participated in the IPWatchdog Life Sciences Masters, which provided insights on the latest updates and trends in intellectual property law and the biopharmaceutical industry.